Mabwell Bioscience Partners with Aditum Bio to Launch Kalexo Bio for siRNA Cardiovascular Therapy#China#Shanghai#Mabwell_Bioscience#Aditum_Bio#Kalexo_Bio
Mabwell Bioscience Partners with Aditum Bio to Launch Kalexo Bio for siRNA Cardiovascular Therapy
Mabwell and Aditum Bio have founded Kalexo Bio to develop innovative siRNA therapies targeting cardiovascular disorders, promising new hope for patients.
third-news.com
September 17, 2025 at 12:09 PM
Mabwell Bioscience Partners with Aditum Bio to Launch Kalexo Bio for siRNA Cardiovascular Therapy#China#Shanghai#Mabwell_Bioscience#Aditum_Bio#Kalexo_Bio